ATE500342T1 - Verfahren zur bestimmung von enzym aktivität - Google Patents

Verfahren zur bestimmung von enzym aktivität

Info

Publication number
ATE500342T1
ATE500342T1 AT03722751T AT03722751T ATE500342T1 AT E500342 T1 ATE500342 T1 AT E500342T1 AT 03722751 T AT03722751 T AT 03722751T AT 03722751 T AT03722751 T AT 03722751T AT E500342 T1 ATE500342 T1 AT E500342T1
Authority
AT
Austria
Prior art keywords
enzyme activity
determining enzyme
relates
measuring enzyme
determining
Prior art date
Application number
AT03722751T
Other languages
English (en)
Inventor
John Gerard Whateley
Original Assignee
Ge Healthcare Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Uk Ltd filed Critical Ge Healthcare Uk Ltd
Application granted granted Critical
Publication of ATE500342T1 publication Critical patent/ATE500342T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2334/00—O-linked chromogens for determinations of hydrolase enzymes, e.g. glycosidases, phosphatases, esterases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2337/00—N-linked chromogens for determinations of peptidases and proteinases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/9015—Ligases (6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT03722751T 2002-04-19 2003-04-17 Verfahren zur bestimmung von enzym aktivität ATE500342T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0208989.4A GB0208989D0 (en) 2002-04-19 2002-04-19 Methods for measuring enzyme activity
PCT/GB2003/001669 WO2003089663A2 (en) 2002-04-19 2003-04-17 Methods for measuring enzyme activity

Publications (1)

Publication Number Publication Date
ATE500342T1 true ATE500342T1 (de) 2011-03-15

Family

ID=9935152

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03722751T ATE500342T1 (de) 2002-04-19 2003-04-17 Verfahren zur bestimmung von enzym aktivität

Country Status (9)

Country Link
US (2) US7727739B2 (de)
EP (1) EP1497452B1 (de)
JP (1) JP4713835B2 (de)
AT (1) ATE500342T1 (de)
AU (1) AU2003229914A1 (de)
CA (1) CA2484467C (de)
DE (1) DE60336217D1 (de)
GB (2) GB0208989D0 (de)
WO (1) WO2003089663A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0113434D0 (en) * 2001-06-04 2001-07-25 Amersham Pharm Biotech Uk Ltd Quinacridone derivatives as labels for fluorescence detection of biological materials
JP4637565B2 (ja) * 2004-11-02 2011-02-23 一般社団法人オンチップ・セロミクス・コンソーシアム 生体試料標識物および生体物質標識法および生体物質の検査法
US7741431B2 (en) * 2005-02-01 2010-06-22 The United States Of America As Represented By The Secretary Of The Army Liposomes containing novel targeting and/or fusogenic peptides, preparations containing them and therapeutic use thereof
US20090220587A1 (en) * 2005-02-01 2009-09-03 United State Army Liposomal drug delivery constructs targeted by lipid-conjugated peptide ligands
US8273530B2 (en) 2005-05-24 2012-09-25 Miho Suzuki Method for simultaneous analysis of multiple biological reactions or changes in in vivo conditions
US9127164B2 (en) 2005-10-28 2015-09-08 Almac Sciences (Scotland) Limited Fluorescent dyes and uses thereof
US8691939B2 (en) 2007-06-08 2014-04-08 General Electric Company Compositions, methods, and kits for assaying complement activation
US20110039289A1 (en) * 2008-03-14 2011-02-17 Pierre Graves Fluorogenic peptides and their method of production
JP2010215572A (ja) * 2009-03-17 2010-09-30 Japan Health Science Foundation 歯髄炎診断マーカー及び歯髄炎診断システム
JP5697129B2 (ja) * 2010-03-24 2015-04-08 国立大学法人埼玉大学 Ｆｒｅｔを利用した酵素活性測定基質及びその製造方法
WO2012110833A2 (en) 2011-02-18 2012-08-23 Almac Sciences (Scotland) Limited Fluorescence modulators
US9180209B2 (en) 2011-02-28 2015-11-10 The Board Of Trustees Of The Leland Stanford Junior University Non-peptidic quenched fluorescent imaging probes
CA2826238A1 (en) 2011-03-25 2012-10-04 Almac Sciences (Scotland) Limited Enzyme assays
WO2012170727A1 (en) * 2011-06-07 2012-12-13 Life Technologies Corporation Fluorogenic semiconductor nanocrystals
KR101372632B1 (ko) * 2011-08-26 2014-03-14 동국대학교 산학협력단 Ｘｐｇ 엔도뉴클레아제 활성 분석 방법
GB201122099D0 (en) 2011-12-22 2012-02-01 Almac Sciences Scotland Ltd Dyes
WO2013142758A1 (en) 2012-03-23 2013-09-26 Surmodics, Inc. Compositions and methods for in vitro diagnostic tests including sulfonic acid
RU2622753C1 (ru) * 2016-11-17 2017-06-19 Федеральное государственное бюджетное учреждение "Национальный научно-практический центр сердечно-сосудистой хирургии имени А.Н. Бакулева" Министерства здравоохранения Российской Федерации (ФГБУ "ННПЦССХ им. А.Н. Бакулева" Минздрава России) Способ определения активности ангиотензин-превращающего фермента в тканях сердца
CN114605405B (zh) * 2022-03-09 2023-09-05 吉林大学 一种基于喹吖啶酮骨架的细胞脂滴荧光成像探针及其应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7801373L (sv) 1978-02-07 1979-08-08 Kabi Ab Lett spjelkbara substrat for kvantifiering av proteaser
DE3268329D1 (en) 1981-11-02 1986-02-13 Pentapharm Ag Process for the quantitative determination of the blood clotting factor xii in human plasma
US4812409A (en) 1986-01-31 1989-03-14 Eastman Kodak Company Hydrolyzable fluorescent substrates and analytical determinations using same
FR2635114A1 (fr) * 1988-08-02 1990-02-09 Cibevial Sa Procede de traitement de solutions proteiques contenant des pigments tels que groupements heminiques ou chlorophylles en vue de leur decoloration et produits obtenus
EP0428000A1 (de) 1989-11-03 1991-05-22 Abbott Laboratories Fluorogene Substrate zum Nachweis von proteolytischer Enzymaktivität
DK93990D0 (da) * 1990-04-17 1990-04-17 Carlsberg As Fluorogene peptider og deres anvendelse ved bestemmelse af enzymatisk aktivitet
GB9310978D0 (en) 1993-05-27 1993-07-14 Zeneca Ltd Compounds
US5508289A (en) 1994-03-14 1996-04-16 The United States America As Represented By The Department Of Health And Human Services Bis-acridone chemotherapeutic derivatives
US5506115A (en) 1994-04-29 1996-04-09 G. D. Searle & Co. Reagent and method for determining activity of herpes protease
US5807746A (en) 1994-06-13 1998-09-15 Vanderbilt University Method for importing biologically active molecules into cells
US5968479A (en) 1995-01-30 1999-10-19 Daiichi Pure Chemicals Co., Ltd. Diagnostic marker
US20010004522A1 (en) 1997-10-28 2001-06-21 Thomas J. Burke Kinase activity measurement using fluorescence polarization
US6194143B1 (en) 1996-12-27 2001-02-27 Boehringer Ingelheim (Canada) Ltd. Substrates for human cytomegalovirus protease
DE19717904A1 (de) 1997-04-23 1998-10-29 Diagnostikforschung Inst Säurelabile und enzymatisch spaltbare Farbstoffkonstrukte zur Diagnostik mit Nahinfrarotlicht und zur Therapie
DE69827260T2 (de) 1997-07-24 2006-02-16 PerSeptive Biosystems, Inc., Framingham Konjugate von transportpeptiden und nukleinsäureanaloga und deren verwendung
US6133445A (en) 1997-12-17 2000-10-17 Carnegie Mellon University Rigidized trimethine cyanine dyes
US6251583B1 (en) 1998-04-27 2001-06-26 Schering Corporation Peptide substrates for HCV NS3 protease assays
AU5429199A (en) * 1998-08-08 2000-02-28 Imperial Cancer Research Technology Limited Modified green fluorescent protein
US6447724B1 (en) * 1998-08-11 2002-09-10 Caliper Technologies Corp. DNA sequencing using multiple fluorescent labels being distinguishable by their decay times
US6207831B1 (en) * 1998-12-21 2001-03-27 Novartis Ag Fluorescent dyes (AIDA) for solid phase and solution phase screening
GB9901072D0 (en) * 1999-01-19 1999-03-10 Imp Cancer Res Tech Methods for detecting changes to a macromolecular component of a cell
US6410255B1 (en) * 1999-05-05 2002-06-25 Aurora Biosciences Corporation Optical probes and assays
CA2374369A1 (en) 1999-05-27 2000-12-07 Merck Frosst Canada & Co. Assays for caspase activity using green fluorescent proteins
US6323186B1 (en) 1999-09-17 2001-11-27 Molecular Probes, Inc. Phosphate-bound polyazaindacene derivatives of nucleotides
GB2357084A (en) 1999-12-06 2001-06-13 Amersham Pharm Biotech Uk Ltd A hydrophobic carrier peptide
AU2002251739A1 (en) 2001-01-05 2002-07-30 The General Hospital Corporation Activatable imaging probes
DE10117430A1 (de) 2001-04-06 2002-10-10 Nicole Marme Hochempfindlicher und hochspezifischer Enzymnachweis mit einer Nachweisgrenze bis in den femtomolaren Bereich
GB0113435D0 (en) 2001-06-04 2001-07-25 Amersham Pharm Biotech Uk Ltd Acridone derivatives as labels for fluorescence detection of target materials
GB0113434D0 (en) 2001-06-04 2001-07-25 Amersham Pharm Biotech Uk Ltd Quinacridone derivatives as labels for fluorescence detection of biological materials

Also Published As

Publication number Publication date
US20100184098A1 (en) 2010-07-22
GB2388190A (en) 2003-11-05
AU2003229914A1 (en) 2003-11-03
JP4713835B2 (ja) 2011-06-29
WO2003089663A2 (en) 2003-10-30
CA2484467C (en) 2012-01-10
EP1497452A2 (de) 2005-01-19
WO2003089663A3 (en) 2004-05-27
DE60336217D1 (de) 2011-04-14
GB0208989D0 (en) 2002-05-29
GB0308910D0 (en) 2003-05-21
CA2484467A1 (en) 2003-10-30
EP1497452B1 (de) 2011-03-02
US20030228609A1 (en) 2003-12-11
US7727739B2 (en) 2010-06-01
JP2005527212A (ja) 2005-09-15
GB2388190B (en) 2004-11-17

Similar Documents

Publication Publication Date Title
ATE500342T1 (de) Verfahren zur bestimmung von enzym aktivität
WO2004055519A3 (en) Specific markers for pancreatic cancer
IL179441A (en) Method of measuring the activity of egln enzyme and of identifying an agent that modulates activity of said enzyme
ATE514755T1 (de) Fluoreszenzfarbstoffe zur verwendung bei der glukoseerfassung
ATE522627T1 (de) Verfahren zur herstellung von nukleinsäuresonden
DE602005021336D1 (de) Verfahren zur identifizierung von proteinen mit stärkephosphorylierender enzymatischer aktivität
WO2006023412A3 (en) Biomarkers for osteoarthritis
ATE540319T1 (de) Verfahren für die bestimmung von fk506
ATE444377T1 (de) Nukleinsäurecharakterisierung
ATE430807T1 (de) Verfahren zur kultivierung von circovirus
DE602005019156D1 (de) Verfahren zur auswertung von ribonukleotidsequenzen
DE602005026855D1 (de) Vorrichtungen und verfahren zur bestimmung von proteaseaktivität
DE602004030372D1 (de) Verfahren zur Bestimmung des relativen genetischen Risikos für Autismus
ATE376428T1 (de) Metallkomplexverbindungen
DE602005013403D1 (de) Verfahren für den nachweis von streptococcus agalactiae mittels alpha-glucosidase-aktivität
MX2009001070A (es) Uso de proteina con actividad inhibidora de melanoma (mia) como un indicador temprano para la respuesta terapeutica en melanoma.
MX2008002123A (es) Metodos y composiciones para determinar un nivel de paraoxonasa de suero biologicamente activa.
DE69913533D1 (de) Reagentien für cyp2d fluoreszenztest
DE602004011228D1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
ATE549404T1 (de) Verfahren zum screening eines transmembranenzymhemmstoffs
ATE373717T1 (de) Pde8a und seine verwendung
FR2875242B1 (fr) Nouveaux substrats enzymatiques derives de phenoxazinone et leur utilisation comme revelateur dans la detection de microorganismes a activite peptidase
DE602007008456D1 (de) Verfahren zur bestimmung von endoglykosidase-(heparanase-)enzymaktivität
AU2003239432A8 (en) PNA probes, probe sets, method and kits pertaining to the determination of listeria
DE10393828D2 (de) Verfahren zur Erkennung von Enzymaktivitäten von beliebigen Proteinextrakten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties